Search clinical trials for: Modulation of FiO2

Total 10000 results

Sanofi
Regeneron Pharmaceuticals

Completed

Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

Colorectal Cancer Metastatic

Italy, Spain, United Kingdom, Czechia, Russian Federation, Norway, Thailand, Chile, Israel, Brazil, United States, Belgium, Canada, Denmark, Finland, Germany, Ireland, Lebanon, Mexico, Netherlands, Puerto Rico, Sweden, Turkey
TRPHARM

Withdrawn

Bioequivalence and Safety Study of Bevacizumab-biosimilar (RPH-001) Compared to Bevacizumab-innovator

Healthy
Beijing Tiantan Hospital
First Affiliated Hospital of Fujian Medical University; Fujian Medical University... and other collaborators

Unknown

Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 2 (EAPCAAMHO2)

Arteriovenous Malformations | Cerebral Aneurysm

China
David M. Brown, M.D.
Regeneron Pharmaceuticals

Completed

Study for Recalcitrant Age Related Macular Degeneration (TURF)

Age Related Macular Degeneration

United States
Thammasat University

Completed

Peri-articular Tranexamic Acid Injection in Total Knee Arthroplasty

Osteoarthritis, Knee

Thailand
Hoffmann-La Roche

Completed

A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Breast Cancer Progressing After First-Line Therapy With Avastin and Chemotherapy (TANIA)

Breast Cancer

Israel, Spain, France, Greece, Germany, Austria, Italy, Hungary, Croatia, Argentina, Brazil, Slovakia, Switzerland
Bayer
Regeneron Pharmaceuticals

Completed

Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF Therapy (POLARIS)

Macular Degeneration | Macular Edema | Ophthalmology

Slovakia, France, Germany, Spain, Russian Federation, United Kingdom, Portugal, Greece
Ursula Schmidt-Erfurth, M.D.

Completed

Bevacizumab Versus Ranibizumab for Diabetic Retinopathy

Diabetic Retinopathy | Diabetic Macular Edema | Proliferative Diabetic Retinopathy

Austria
Yonsei University

Completed

Intravitreal Ranibizumab in Exudative Age-related Macular Degeneration With Posterior Vitreomacular Adhesion

Neovascular Age-related Macular Degeneration

Korea, Republic of
Innate Pharma

Completed

Study on the Safety, Anti-tumor Activity and Pharmacology of IPH2101 Combined With Lenalidomide in Patients With Multiple Myeloma Experiencing a First or Second Relapse (KIRIMID)

Patients With Multiple Myeloma Experiencing a | First or Second Relapse

United States
Tang-Du Hospital

Unknown

Efficacy and Safety of Bevacizumab Versus Pulvis Talci in Malignant Pleural Effusion

Malignant Pleural Effusion

China
Peter MacCallum Cancer Centre, Australia
Celgene Corporation

Unknown

Lenalidomide and Recombinant Human Stem Cell Factor for Treatment of Myelodysplasia

Myelodysplasia

Australia
W.L.Gore & Associates

Completed

GORE VIABAHN Endoprosthesis With Heparin Bioactive Surface in the Treatment of SFA Obstructive Disease (VIPER) (VIPER)

Peripheral Vascular Diseases

United States
University of Sao Paulo

Completed

Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic Retinopathy

Cardiovascular Diseases | Vascular Diseases | Eye Diseases | Diabetic Angiopathies | Retinal Diseases | Diabetic Retinopathy

Brazil
Johann Wolfgang Goethe University Hospital

Completed

Bevacizumab Versus Micropulse in Central Serous Chorioretinopathy (CSC)

Central Serous Chorioretinopathy

Germany
Ferring Pharmaceuticals

Completed

Lysteda Pediatric Research Equity Act (PREA) Pharmacokinetic Study in Adolescent Females With Heavy Menstrual Bleeding (PREA)

Menorrhagia

United States
Azienda Ospedaliero, Universitaria Pisana

Completed

First-line FOLFOXIRI Plus Bevacizumab in BRAF Mutant Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

Italy
University of Molise

Completed

Aqueous Vascular Endothelial Growth Factor (VEGF) Levels in Type 3 Neovascularization

Age-related Macular Degeneration

Italy
University Health Network, Toronto
The Physicians' Services Incorporated Foundation

Completed

Topical Tranexamic Acid for Total Knee Arthroplasty

Total Knee Arthroplasty | Surgical Blood Loss

Canada
Fudan University

Unknown

Recombinant Human Endostatin in Combination With mFOLFOX6 in Patients With Metastatic Colorectal Cancer

Colorectal Neoplasm

China
Dana-Farber Cancer Institute
Massachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaborators

Completed

Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme

Glioblastoma | Gliosarcoma | Malignant Gliomas

United States
Ontario Clinical Oncology Group (OCOG)
Pfizer

Completed

Fragmin in Ovarian Cancer: Utility on Survival (FOCUS)

Ovarian Cancer

Canada
The Ludwig Boltzmann Institute of Retinology and...

Completed

Systemic Avastin Therapy in Age-Related Macular Degeneration (BEAT-AMD)

Macular Degeneration

Austria
Hamilton Health Sciences Corporation
St. Joseph's Health Care London

Completed

Patients Preference With Self-Injection: The PRISM Study

Bruises

Canada
National Institute of Allergy and Infectious Diseases...

Completed

Subcutaneously Administered Interleukin-12 Therapy in HIV-Infected Patients With Disseminated Mycobacterium Avium Complex Infection

Acquired Immunodeficiency Syndrome | Mycobacterium Avium-Intracellulare Infection

United States
Singapore National Eye Centre

Unknown

Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous Maculopathy

Polypoidal Choroidal Vasculopathy | Choroidal Neovascularisation
Hamilton Health Sciences Corporation
Pfizer; Canadian Critical Care Trials Group

Completed

Dalteparin's Influence on Renally Compromised: Anti-Ten-A Study (DIRECT)

Renal Insufficiency

Canada
Grupo Español de Linfomas y Transplante Autólogo...
AbbVie; Incyte Corporation; Evidenze Health España (CRO)

Recruiting

Response-adaptive to Epcoritamab In First Relapse: Study to Evaluate the Efficacy of Eptoritamab in Patients With Relapse/Refractory Large B Cell Lymphoma (REPIFIR)

Large B Cell Lymphoma

Spain
Nantes University Hospital

Not yet recruiting

Comparison of Elranatamab and Lenalidomide Versus Daratumumab and Lenalidomide as Post-transplant Maintenance Therapy in Patients With Newly Diagnosed Myeloma (ElMMA) (IFM 2024_06)

Multiple Myeloma

France
Zhongming Qiu
The Second Affiliated Hospital of Chongqing Medical University; Mianyang Central... and other collaborators

Not yet recruiting

Tirofiban for Successful Endovascular Stroke Thrombectomy (ADJUVANT-2)

Stroke, Acute Ischemic
University Medical Center Groningen

Not yet recruiting

Safety and Feasibility of Immuno-OCT (DETOUR)

Barrett Esophagus | Colon Carcinoma | Gastrointestinal Dysplasia
Instituto Mexicano del Seguro Social

Recruiting

Tranexamic Acid in Debridement Surgery of Burns on the Volume of Bleeding in Transfusion Requirements

Burns

Mexico
Fudan University

Recruiting

The Efficacy and Safety of Fruquintinib Plus Chemotherapy as Second-line Treatment in Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

China
Fudan University

Recruiting

VIC Regimen Versus Bevacizumab Plus Chemotherapy as First-Line Treatment for BRAF V600E-Mutated Advanced Colorectal Cancer

Colorectal Cancer

China
Puyang Oilfield General Hospital

Not yet recruiting

Orelabrutinib in Combination With R2 Regimen for R/R CD20+ B-cell Lymphoma

B-cell Lymphoma
Centre Hospitalier Universitaire Dijon

Recruiting

A Randomized Phase III Study Comparing Maintenance Treatment With Fluoropyrimidine + Bevacizumab Versus Fluoropyrimidine After Induction Chemotherapy for a Metastatic Colorectal Cancer (BEVAMAINT)

Metastatic Colorectal Cancer

France
Beijing Friendship Hospital

Recruiting

PD1 Antibody and Lenalidomide as a Treatment for EBV-HLH or CAEBV

EBV Infection

China
Innostellar Biotherapeutics Co.,Ltd

Active, not recruiting

Safety and Efficacy of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (VENUS)

Neovascular Age-Related Macular Degeneration

China
Bioeq GmbH

Completed

Efficacy and Safety of the Aflibercept FYB203 Biosimilar in Comparison to Eylea® in Patients With Neovascular Age-Related Macular Degeneration (MAGELLAN-AMD)

Neovascular Age-related Macular Degeneration

Bulgaria, Italy, Hungary, Poland, Ukraine, Japan, Czechia, Israel, Russia
Almirall, S.A.

Completed

Observational Real-world Evidence (RWE) Study to Assess Patient-reported Wellbeing Using Tildrakizumab in Live Setting - POSITIVE Study (POSITIVE)

Plaque Psoriasis

Germany
ApcinteX Ltd
Centessa Pharmaceuticals plc

Terminated

The Efficacy and Safety of SerpinPC in Participants with Severe Hemophilia a or Moderately Severe to Severe Hemophilia B (PRESent-2)

Hemophilia B | Hemophilia a

United Kingdom, United States, Australia, Belgium, Spain, Taiwan, France, Turkey, Italy, Canada, Poland, South Africa, Germany, India, Armenia
Northwestern University
Northwestern Memorial Hospital; Saint Joseph Hospital, Chicago, Illinois

Withdrawn

Tranexamic Acid Usage in Bilateral Mastectomy to Reduce Post-surgical Drainage

Breast Cancer | BRCA Mutation

United States
Alvotech Swiss AG

Completed

Clinical Study to Compare Efficacy and Safety of AVT06 and EU-Eylea (ALVOEYE) (ALVOEYE)

Neovascular (Wet) AMD

Slovakia, Czechia, Georgia, Japan, Latvia
Innovent Biologics (Suzhou) Co. Ltd.

Completed

A Study of Longer Interval of IVT IBI302 in Subjects With nAMD

Neovascular Age-related Macular Degeneration

China
Bayer
Regeneron Pharmaceuticals

Completed

Routine Clinical Practice for Use of Intravitreal Aflibercept Treatment in Patients With Diabetic Macular Edema (APOLLON)

Diabetic Retinopathy

France
Hoffmann-La Roche

Completed

A Study in Patients With Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema to Evaluate the Safety of the Faricimab Prefilled Syringe

Diabetic Macular Edema | Neovascular Age-related Macular Degeneration

United States
Erasmus Medical Center
DUMAS is sponsored by an unrestricted grant from Thrombolytic Science International...

Completed

Dual Thrombolytic Therapy With Mutant Pro-urokinase and Low Dose Alteplase for Ischemic Stroke (DUMAS)

Ischemic Stroke

Netherlands
Ribomic USA Inc

Completed

A Phase II Study of RBM-007 Alone and RBM-007 With Eylea® in Subjects With Wet Age-related Macular Degeneration (TOFU)

Exudative Age-related Macular Degeneration

United States
Seoul National University Hospital

Completed

Acalabrutinib With Rituximab and Lenalidomide in Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Non-hodgkin Lymphoma,B Cell

Korea, Republic of
Haisco Pharmaceutical Group Co., Ltd.

Completed

A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Dosed of HSK36273 in Healthy Volunteers

Healthy

China

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations